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Abstract 
Bipolar pulsed electromagnetic stimulation applied to the brain (T-PEMF) is a non-pharmaco-
logical treatment which has been shown to stimulate nerve growth, attenuate nerve abnor-
malities, and improve microcirculation. We report on a 62-year-old, medically well-treated man 
with idiopathic Parkinson’s disease. He was treated with T-PEMF, 30 min per day for three 8-
week periods separated by two 1-week breaks. The disease made his handwriting impossible 
to read mainly due to small letters and lack of fluency. Forearm EMG measured during stand-
ardized conditions showed an involuntary spiky EMG pattern with regular burst activity (on his 
left side) at baseline. The intervention normalized the handwriting and forearm EMG. The 
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UPDRS-motor score decreased from 25 to 17, and UPDRS-II-handwriting decreased from a 
pre-intervention value of 3 to 0 after the intervention. Finally, the patient reported improved 
fine motor function, less muscle stiffness, less muscle cramps and tingling, and less fatigue 
during the day in response to the T-PEMF treatment. The improved handwriting lasted for 
approximately 3 months after the treatment. Our results should be considered as preliminary, 
and large-scale, controlled studies are recommended to elucidate the therapeutic potential of 
long-term treatment with T-PEMF. © 2018 The Author(s) 
 Published by S. Karger AG, Basel 
Background 
Impaired fine motor skills and tremor are common in Parkinson’s disease (PD). It is com-
monly accepted that the origin of the tremor is in the central nervous system, although the 
exact pathophysiological mechanisms leading to Parkinsonian tremor are still discussed. Sev-
eral hypotheses regarding the origin of tremor have been proposed in the literature. There 
seems to be evidence that both the basal ganglia and the cerebello-thalamo-cortical loop are 
involved in Parkinsonian tremor. Activity in the basal ganglia is primarily affected by dopa-
mine depletion in PD. Recently, a new model, the “dimmer-switch-model,” has been proposed. 
The model combines features of previous hypotheses into a complex model. The dimmer-
switch-model explains tremor as resulting from the combined action of two neural circuits: 
the basal ganglia that trigger tremor-related responses in the cerebello-thalamo-cortical cir-
cuit initiate the tremor (switch) and the cerebello-thalamo-cortical circuit produces the 
tremor and modulates tremor intensity (dimmer). Further, the model suggests that these in-
teractions occur in the motor cortex where the two circuits converge [1, 2]. Tremor is associ-
ated with rhythmic, bursty, neuronal firing and is clearly visible on surface electromyographic 
(EMG) recordings [3]. 
Treatment with bipolar pulsed electromagnetic fields (PEMF) is a non-invasive, rapidly 
emerging technique. The biophysical effects of PEMF are to depolarize the membrane poten-
tial slightly and to induce ion currents in the tissue [4]. The technique (in animals and in vitro) 
seems to enhance cellular activity and stimulate growth-related responses and regeneration 
[4]. For example, PEMF has been shown to stimulate nerve growth and attenuate nerve ab-
normalities, to increase the microvascular blood flow and tissue oxygenation, and to increase 
capillary density [5–8]. Thus, a connection between pulsed electromagnetic fields and the 
physiological response must exist. Treatment with PEMF constitutes a new, potential, non-
pharmacological treatment method of PD when applied transcranially to the brain (T-PEMF). 
The patient presented in this case report participated in an ongoing study on the effects 
of long-term treatment with T-PEMF. In this study, we focus on tremor characteristics, muscle 
activation, and gross motor function in terms of movement speed and functional rate of force 
development. The reason why this particular patient is presented as a case report was that he 
produced a detailed written report on signs and symptoms and conducted writing tests during 
and after the treatment period on his own initiative and blinded to the researchers. The re-
searchers received the patient report and the writing tests after the end of the treatment. 
These data raised the question whether there were any systematic changes in the activation 
of the forearm muscles in response to the T-PEMF treatment that could be documented.  
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Case Report 
We report on a male patient (age 62 years, body weight 73 kg, height 1.77 m) who had 
been diagnosed with PD according to the UK Brain Bank criteria 6 years prior to participation. 
Total score of the Unified Parkinson Disease Rating Scale (UPDRS) was 50, UPDRS-motor was 
25, UPDRS-II-handwriting was 3, Hoehn and Yahr stage was 2, and Mini-Mental State Exami-
nation score was 30 at baseline. The patient was left-handed, and the left side was most af-
fected. The patient received 1,010 mg/24 h levodopa equivalent dose (Selegeline, Ropinirole, 
levodopa/benserazide). The patient was medically well-treated, and the medication had not 
been changed for more than 6 weeks prior to or throughout the T-PEMF intervention period. 
The patient had no family history of PD. The patient’s handwriting was characterized by dim-
inution of letter size, a tendency to progressive reduction in size, and lack of fluency, which 
made his handwriting unreadable at baseline.  
The patient was treated with T-PEMF (home-based) in three periods of 8 weeks’ duration 
separated by a 1-week pause between the treatment periods. Thus, the total intervention pe-
riod was 26 weeks. Each treatment period included one daily treatment of 30 min duration. 
No sham treatment was performed. T-PEMF was performed through 7 coils placed in a hel-
met-like shape, with one coil in the central occipital region, one in the frontal-parietal region 
(bilateral), and two in the anterior-temporal and posterior-temporal region (bilateral) (Re5 
NTS Parkinson Treatment System, Re5, Frederiksberg, Denmark). The coils were connected 
to an external pulse generator which generated bipolar, squared pulses (amplitude approxi-
mately 50 V, duration 3 ms, frequency 55 Hz) to initiate rapid changes in the currents in the 
coils, which gave rise to a time-dependent, rapidly changing electromagnetic field. The elec-
tromagnetic field penetrates through electrically insulated tissue, such as, for example, the 
skull, and induces a driving force on the charged particles (peak E-field intensity approxi-
mately 2.5 mV/cm near the coil) and thereby electrical currents in the brain (Table 1).  
The outcomes in the present case report are forearm muscle activation, handwriting per-
formance, and reported observations. In addition, UPDRS was measured before and after the 
intervention. All measurements were performed in self-reported on-phase. Surface EMG (MQ-
15, Marq Medical, Denmark) was recorded from wrist/finger extensor and wrist flexor mus-
cles (bilaterally). EMG was recorded with the patient seated on a chair (no back support), the 
shoulders 90 degrees flexed, elbows stretched, arms parallel, palms facing the floor, and an 
external load of 0.480 kg in each hand (power grip). EMG was measured at baseline (week 0), 
after 2 periods of T-PEMF treatment (week 17), and on the day after the last T-PEMF treat-
ment (week 27). Measurements of EMG at the three time points during the treatment period 
were repeated twice for each time point. Each recording lasted 25 s. Handwriting tests, per-
formed during the treatment period, were saved by the patient and shown to the researchers 
after the end of the treatment. Observations regarding status and changes in motor and non-
motor signs and symptoms were reported by the patient and the patient’s family. The re-
ported observations were given in written form to the researchers after the end of the treat-
ment. EMG results, handwriting tests, and patient observations are presented in Figures 1, 2, 
and 3, respectively. The total UPDRS score was 38, UPDRS-motor was 17, and UPDRS-II-hand-
writing was 0 after the intervention. 
In addition, the patient performed writing tests at 2, 7, 11, and 16 weeks after the treat-
ment. The patient’s improved writing performance was largely maintained for at least 11 
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weeks. At week 16 after the intervention, a marked impairment was seen (online suppl. Fig.; 
for all online suppl. material, see www.karger.com/doi/10.1159/000492486).  
Discussion 
The patient had been diagnosed with PD 6 years prior to participation. Handwriting im-
pairment was among the patient’s first visible signs. Surface EMG was measured on the wrist 
extensor and flexor muscles during a bilateral, prolonged, low-level, static contraction. A static 
muscle activation pattern was, therefore, expected bilaterally, in both the extensor and flexor 
muscles, and with the highest activation level in the extensor muscles. The expected muscle 
activation pattern was found for the muscles on the right side, which was the patient’s less 
affected side (Fig. 1). However, on the left side, a spiky EMG pattern with regular burst activity 
was measured in the extensor muscles and to some extends in the flexor muscles throughout 
the contractions at baseline. Such an EMG pattern is common in PD and can result in tremor. 
However, tremor is the mechanical manifestation of involuntary, intermittent muscle activa-
tion, and it occurs when the internal torque generated by the muscles exceeds the external 
torque generated by gravity. Thus, consequently, involuntary EMG burst activity can occur 
without visible tremor when the internal torque is less than the external torque. However, this 
type of involuntary muscle activation pattern can certainly disturb fine motor skills, such as, 
for example, writing ability, due to a lack of force and movement control.  
Figure 2 shows the patient’s handwriting performance at different time points. Handwrit-
ing is a complex motor activity, and dysfunction is a major and common disabling sign of PD, 
although not included in the diagnosis. In accordance, the lack of readability of his handwrit-
ing was a major problem for the patient at baseline. The patient’s handwriting was signifi-
cantly improved after the treatment period compared to baseline. This is, letter size was in-
creased, and his writing was much more fluent and certainly readable. Handwriting disability 
is associated with decreased activity and connectivity in the basal ganglia motor circuit [9]. 
Furthermore, writing ability and tremor share a common correlate, dopamine, in PD [10–12]. 
Therefore, it is hypothesized that long-term treatment with T-PEMF increases the level of do-
pamine in the brain [13].  
EMG measurements at week 17 clearly showed a changed activation pattern of the left 
forearm muscles compared to baseline. The spiky muscle activation pattern had disappeared, 
and a pattern corresponding to the right-side EMG was found. The same static activation pat-
tern was found after the third 8-week treatment period. In parallel with this, the three 8-week 
periods of treatment with T-PEMF improved the readability and the quality of the patient’s 
handwriting significantly as shown in Figure 2. In accordance, UPDRS-II-handwriting was re-
duced from 3 to 0 during the treatment period. The major improvement was found after the 
first two 8-week periods of treatment.  
In addition, the patient reported improved fine motor function, less muscle stiffness, and 
less muscle cramps and tingling in response to the T-PEMF treatment. Furthermore, he expe-
rienced less fatigue during day time and became happier (Fig. 3). The improved writing ability 
after the treatment lasted approximately 3 months, indicating a long-term effect.  
The present T-PEMF treatment differs significantly from rTMS regarding number of stim-
ulation sites, intensity, frequency, stimuli per session, number of sessions, duration, and 
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location (Table 1) [14, 15]. Thus, T-PEMF induces a high number of weak, pulsating, electric 
fields in the brain tissue. The electric field is strong enough to cause protein activation but 
weaker than the limit for eliciting action potentials of brain cells and for opening voltage-de-
pendent Na+ channels [4].  
In conclusion, it seems likely that the improved motor control, e.g., writing ability, is as-
sociated with the present normalization of forearm muscle activation and that this is an effect 
of long-term treatment with T-PEMF. The presented results should be considered as prelimi-
nary, and the effects of T-PEMF should be studied in large-scale, controlled studies to elucidate 
the therapeutic potential of the new technique.  
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Fig. 1. EMG findings during a standardized, low-level, isometric contraction. Surface EMG recorded from 
the forearm extensor and flexor muscles. 0, at baseline; 17, after two 8-week periods with T-PEMF treat-
ment; 27, after three 8-week periods with T-PEMF treatment. 
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Fig. 2. Handwriting performed before, during, and after the treatment with T-PEMF. a Micrographia before 
the initiation of the treatment. b Handwriting test performed after the first two treatment periods. Letter 
size has increased significantly. c Handwriting test performed after the end of the treatment. The patient’s 
handwriting is now normalized.  
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Fig. 3. Observations reported by the patient. 
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Table 1. Characteristics of the presented T-PEMF stimulation method versus typical high- and low-frequency 
rTMS [4, 14, 15] 
    
    
 T-PEMF High-frequency rTMS Low-frequency rTMS 
    
    
Sites, n 7 1 (or 2) 1 (or 2) 
Brain target large  small small  
Coil circular circular/figure 8 circular/figure 8 
Intensity about 6th order of magni-
tude less than motor thresh-
old 
approximately active or 
rest motor threshold 
approximately active or 
rest motor threshold 
Frequency, Hz 55 5–25 (50) ≤1 
Stimuli/session 99,000 450–3,000 60–1,800 
Sessions (total) 168 1–10 1–10 
Duration 3 × 8 weeks 1 day to 8 weeks 1 day to 8 weeks  
Treatment location home clinic clinic 
    
    
 
 
 
